A PHP Error was encountered

Severity: Warning

Message: file_get_contents(https://...@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests

Filename: helpers/my_audit_helper.php

Line Number: 176

Backtrace:

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 176
Function: file_get_contents

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 250
Function: simplexml_load_file_from_url

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 1034
Function: getPubMedXML

File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3152
Function: GetPubMedArticleOutput_2016

File: /var/www/html/application/controllers/Detail.php
Line: 575
Function: pubMedSearch_Global

File: /var/www/html/application/controllers/Detail.php
Line: 489
Function: pubMedGetRelatedKeyword

File: /var/www/html/index.php
Line: 316
Function: require_once

Amikacin therapeutic drug monitoring: Evaluation of therapy performance and analytical techniques in a developing country setting. | LitMetric

Introduction: Healthcare systems face several challenges, with microbial infections being one of the main concerns. Therapeutic drug monitoring (TDM) is a strategy that has been encouraged to optimize antimicrobial regimens, particularly those with significant toxicity and narrow therapeutic indices, such as amikacin (AMK). We aimed to evaluate AMK concentrations of patients in a non-routine TDM setting and compare the performance of immunoassay and chromatography methods for routine clinical use.

Material And Methods: In this prospective study, peak (C) and trough (C) plasma samples were collected from 39 adult patients and quantified by ultra-performance liquid chromatography coupled with mass spectrometry (UPLC-MS/MS). Relevant clinical information was collected from medical records. AMK concentrations and clinical data were analyzed to evaluate therapy performance and influencing factors. In addition, fluorescence polarized immunoassay (FPIA) and UPLC-MS/MS were compared with Passing-Bablok regression and Bland-Altman plot analysis.

Results: AMK concentrations varied widely, with a median C of 41.40 µg/mL (interquartile range [IQR] 27.60 - 56.75 µg/mL) and a median C of 1.87 µg/mL (IQR 0.7 - 6.19 µg/mL). A high proportion of patients (83.1 %) failed to achieve the C therapeutic target, while 31.7 % failed to achieve the C therapeutic target. Overall, elderly patients and those with reduced renal function had higher C target attainment, while the same groups had lower C target attainment. The method comparison showed a mean difference of 1.54 % (limits of agreement -42.46 % to 45.54 %) in measured concentrations, with good correlation and no constant or proportional differences.

Conclusion: Many patients failed to reach the C target and were at risk of treatment failure, although adequate C was achieved more often. TDM with dose adjustments could improve AMK therapy, but further research is needed.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clinbiochem.2025.110874DOI Listing

Publication Analysis

Top Keywords

amk concentrations
12
therapeutic drug
8
drug monitoring
8
therapy performance
8
failed achieve
8
achieve therapeutic
8
therapeutic target
8
target attainment
8
amk
5
patients
5

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!